<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03466645</url>
  </required_header>
  <id_info>
    <org_study_id>Isfahan University</org_study_id>
    <nct_id>NCT03466645</nct_id>
  </id_info>
  <brief_title>The Effectiveness of Vancomycin in Comarison With Cefazolin in Prevention of SSI After Craniotomy</brief_title>
  <official_title>The Effectiveness of Vancomycin in Comarison With Cefazolin in Prevention of SSI After Craniotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Isfahan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Isfahan University of Medical Sciences</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgical-site infection is the most commonly reported nosocomial infection in patients
      undergoing surgery and 3rd most nosocomial infection in hospitalized patients. The SSI is
      associated with increases of length of hospitalization for 6 days and increases the
      hospital's cost by $ 300.

      Because of these, prevention of SSI with appropriate antibiotic is essential.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2018</start_date>
  <completion_date type="Anticipated">August 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2019</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>infection rate</measure>
    <time_frame>Until 90 days after admission</time_frame>
    <description>compare of infection rate in 2 groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>length of hospitalization</measure>
    <time_frame>Until 90 days after admission</time_frame>
    <description>compare the length of hospitalization in 2 groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>raise of ESR &amp; CRP</measure>
    <time_frame>Until 90 days after admission</time_frame>
    <description>compare the raise of ESR &amp; CRP in 2 groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Elective Craniotomy-candidated Patients</condition>
  <arm_group>
    <arm_group_label>1st group, receiving vancomycin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The 1st group receives vancomycin an hour before craniotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2nd group, receiving cefazolin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The 2nd group receives cefazolin an hour before craniotomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vancomycin</intervention_name>
    <description>The 1st group receives vancomycin an hour before craniotomy</description>
    <arm_group_label>1st group, receiving vancomycin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cefazolin</intervention_name>
    <description>The 2nd group receives cefazolin an hour before craniotomy</description>
    <arm_group_label>2nd group, receiving cefazolin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18 years and above

          -  elective surgical patients

          -  No pre-surgery infection

          -  Do not use antibiotics before surgery

          -  Insensitivity to beta-lactam antibiotics

        Exclusion Criteria:

          -  cranioplasty

          -  Failure to follow the patient

          -  The patient's unwillingness to continue participating in the research project

          -  Death of the patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rasool Mohammadi, Student</last_name>
    <phone>+989365725957</phone>
    <email>rasool.mohammadi1993@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Isfahan university of medical science.</name>
      <address>
        <city>Isfahan</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rasool Mohammadi, student</last_name>
      <phone>+989365725957</phone>
      <email>rasool.mohammadi1993@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2018</study_first_submitted>
  <study_first_submitted_qc>March 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2018</study_first_posted>
  <last_update_submitted>March 9, 2018</last_update_submitted>
  <last_update_submitted_qc>March 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Isfahan University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Leila Dehghani</investigator_full_name>
    <investigator_title>The effectiveness of vancomycin in comparison with cefazolin in prevention of SSI after craniotomy</investigator_title>
  </responsible_party>
  <keyword>SSI</keyword>
  <keyword>elective Craniotomy</keyword>
  <keyword>Vancomycin</keyword>
  <keyword>Cefazolin</keyword>
  <keyword>Antibiotic</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vancomycin</mesh_term>
    <mesh_term>Cefazolin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

